Methodology

All entries for: Adolore BioTherapeutics

November 9, 2025

Adolore BioTherapeutics

Orphan Drug Designation

FDA orphan drug designation: treatment of erythromelalgia

Disease Area: Rare Diseases
Source
Source
Scroll to Top